CardioCel 3D - A revolution is coming.

There were many amazing highlights from last weeks webinar although it's the upcoming release of CardioCel 3D, the curved patch for aortic repair, which I thought was THE highlight.

Three main reasons being....

- There is NO OTHER company in the world which can make a specialised patch for aortic repair like this. They have tried and they have failed although Admedus HAS succeeded. This is a unique accomplishment which will have an impact across our WHOLE tissue range as the Admedus name will be immediately associated with excellence and superiority and making history. CardioCel, CardioCel Neo and VascuCel ALL stand to gain by association from the release of CardioCel 3D.

- When Admedus reached out in a poll to gauge interest in this revolutionary product 85% of surgeons asked said they would use the product IMMEDIATELY. This is a massive commitment on behalf of these surgeons and signals that initial demand will be very very strong. Especially encouraging as the product will be priced at a large premium (to compliment it's uniqueness.) Initial demand will have a massive impact on the company's top line and in the near future also its bottom line, profit. Process validation begins in March, may have begun already, FDA submission set for April and FIRST implants set for JUNE (pre-launch.) The 1st quarter of FY18 is going to be amazing.

- The release of CardioCel 3D is coming at exactly the right time in the company's manufacturing evolution. The cost of goods sold (the cost to maufacture per unit) has come down from $704 to $390, a 45% reduction, And Wayne has said that they're going to be coming down even further, much further, so this will be huge for the company's profit margins and future profits.

I'd be very interested to hear other people's thoughts on this, thanks.